CAR-T has been hailed as a cure for cancer, but what really is this miraculous technology and what can we actually expect when it reaches the market?
The field of immuno-oncology is booming with billions of euros in investment. The ability to rewire our own immune system to fight cancer has certainly created huge expectations. After the success of the first checkpoint inhibitors on the market, many are turning their attention to CAR-T therapy, the next big cancer therapy to hit the market.
There are now almost 300 CAR-T clinical trials running, and the first CAR-T could be approved as soon as by the end of this year. But is this therapy really a cure for cancer, as many seem to believe? Can the technology meet such high expectations? Are the recent deaths in clinical trials a sign that CAR-T is not ready for commercialization? What will the future bring?
Complete article is at: http://labiotech.eu/car-t-therapy-cancer-review/